Investing in the future of railway safety: Company behind KAVACH project launches IPO – should you invest?
Investing in the future of railway safety: Company behind KAVACH project launches IPO – should you invest?
In this analysis, we take a closer look at Quadrant Future Tek Ltd and present you with the exclusive IPO details.
In this analysis, we take a closer look at Quadrant Future Tek Ltd and present you with the exclusive IPO details.
Don't miss this fundamentally strong company's IPO backed by robust grey market demand!
Between FY22 and FY24, the company recorded a Compound Annual Growth Rate (CAGR) of around 51 per cent in revenue and 54 per cent in net profit.
Between FY22 and FY24, the company recorded a Compound Annual Growth Rate (CAGR) of around 51 per cent in revenue and 54 per cent in net profit.
Upcoming IPO with around 40 per cent GMP: Should you consider investing?
In this IPO analysis, we take a closer look at Indo Farm Equipment Ltd and present you with exclusive details.
In this IPO analysis, we take a closer look at Indo Farm Equipment Ltd and present you with exclusive details.
Skyrocketing success: This aerospace IPO gets fully subscribed within hours; have you boarded the flight?
Between FY22 and FY24, the company recorded a Compound Annual Growth Rate (CAGR) of around 140 per cent in revenue and 314 per cent in net profit.
Between FY22 and FY24, the company recorded a Compound Annual Growth Rate (CAGR) of around 140 per cent in revenue and 314 per cent in net profit.
Too many IPOs at a time: Should you invest in Carraro India IPO?
Between FY22 and FY24, the company recorded a Compound Annual Growth Rate (CAGR) of around 10 per cent in revenue and 67 per cent in net profit.
Between FY22 and FY24, the company recorded a Compound Annual Growth Rate (CAGR) of around 10 per cent in revenue and 67 per cent in net profit.
Ventive Hospitality IPO: A gateway to luxury growth
Between FY22 and FY24, it achieved a Compound Annual Growth Rate (CAGR) of 44 per cent in revenue and a remarkable 138 per cent in net profit.
Between FY22 and FY24, it achieved a Compound Annual Growth Rate (CAGR) of 44 per cent in revenue and a remarkable 138 per cent in net profit.
Triple-digit CAGR pharma player hits the market: Should you invest?
Between FY22 and FY24, the company recorded a Compound Annual Growth Rate (CAGR) of around 285 per cent in revenue and 472 per cent in net profit.
Between FY22 and FY24, the company recorded a Compound Annual Growth Rate (CAGR) of around 285 per cent in revenue and 472 per cent in net profit.
Can this wastewater treatment provider’s IPO match the success of its peers?
The company's peers, Enviro Infra Engineers Ltd and VA Tech Wabag Ltd, delivered multibagger returns to investors!
The company's peers, Enviro Infra Engineers Ltd and VA Tech Wabag Ltd, delivered multibagger returns to investors!
IPO Analysis: Will this textile company sew up your portfolio gains?
The company delivered a decent return on equity (RoE) of 11 per cent and a return on capital employed (RoCE) of 12 per cent for FY24.
The company delivered a decent return on equity (RoE) of 11 per cent and a return on capital employed (RoCE) of 12 per cent for FY24.
EPC Powerhouse IPO expects 28 per cent listing gains: Is it time to subscribe?
The IPO is showing a strong premium in the grey market ahead of its launch. Read on to discover the recommended course of action.
The IPO is showing a strong premium in the grey market ahead of its launch. Read on to discover the recommended course of action.
DAM Capital Advisors IPO: A gateway to India's capital market boom
From FY22 to FY24, the company achieved a Compound Annual Growth Rate (CAGR) of around 39 per cent in revenue and around 80 per cent in net profit.
From FY22 to FY24, the company achieved a Compound Annual Growth Rate (CAGR) of around 39 per cent in revenue and around 80 per cent in net profit.
IPO Analysis: Blue Jet Healthcare Ltd
IPO Rating: Apply for the long-term
IPO Rating: Apply for the long-term